Finance

Lists
LENZ:NASDAQ
Lenz Therapeutics Inc
၃.၅၃ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၉, GMT-၄ ၁၀:၁၃:၃၈  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LENZ...
Open
၃.၅၃ US$
High
၃.၅၆ US$
Low
၃.၄၂ US$
Mkt. cap
၁၁.၀၉ ကုဋေ
Avg. vol.
၇.၅၄ သိန်း
Volume
၇.၀၄ သောင်း
52-wk high
၄၆.၇၅ US$
52-wk low
၃.၃၅ US$
EPS
-၄.၀၈ US$
Beta
၀.၆၅
Shares outstanding
၃.၁၄ ကုဋေ
No. of employees
၁၅၂
Open
၃.၅၃ US$
High
၃.၅၆ US$
Low
၃.၄၂ US$
Mkt. cap
၁၁.၀၉ ကုဋေ
Avg. vol.
၇.၅၄ သိန်း
Volume
၇.၀၄ သောင်း
52-wk high
၄၆.၇၅ US$
52-wk low
၃.၃၅ US$
EPS
-၄.၀၈ US$
Beta
၀.၆၅
Shares outstanding
၃.၁၄ ကုဋေ
No. of employees
၁၅၂
News stories
From web sources and news partners
About Lenz Therapeutics Inc
CEO-
Employees၁၅၂
Founded၂၀၁၃
HeadquartersSolana Beach, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to LENZ in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for LENZ in the last 3 months.
Highest
Current ၃.၅၃ US$
၆၀.၀၀ US$ (+၁,၅၉၉.၇၂%)
Average
၂၄.၄၀ US$ (+၅၉၁.၂၂%)
Lowest
၇.၀၀ US$ (+၉၈.၃၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Gerberry
Bank of America Securities
Hold
Downgraded
၇.၀၀ US$
+၉၈.၃%
08/12/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
08/12/2026
Biren Amin
Piper Sandler
Hold
Maintained
၇.၀၀ US$
+၉၈.၃%
08/12/2026
Yigal Nochomovitz
Citi
Buy
Maintained
၁၀.၀၀ US$
+၁၈၃.၃%
08/13/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
၃၈.၀၀ US$
+၉၇၆.၅%
08/12/2026
Stacy Ku
TD Cowen
Buy
Reiterated
၆၀.၀၀ US$
+၁,၅၉၉.၇%
08/12/2026
Last report
၂၀၂၆ ဩ ၁၁
Fiscal period
Q2 2026
EPS / Est. (USD)
-၁.၀၂ US$ / -၁.၀၇ US$
+၅.၁၀%beat
Revenue / Est. (USD)
၅.၄၉ သန်း / ၂.၃၈ သန်း
+၁၃၀.၇၆%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၂၅ ကုဋေ
၁.၅၉ သန်း
၁.၉၀ သန်း
၅.၄၉ သန်း
Cost of goods sold
-
၄.၁၈ သိန်း
၁.၀၈ သန်း
၂.၈၀ သိန်း
Cost of revenue
-
၄.၁၈ သိန်း
၁.၀၈ သန်း
၂.၈၀ သိန်း
Research and development expenses
၃.၇၉ သန်း
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၇၆ ကုဋေ
၃.၉၆ ကုဋေ
၄.၅၀ ကုဋေ
၃.၉၄ ကုဋေ
Operating expense
၃.၁၄ ကုဋေ
၃.၉၆ ကုဋေ
၄.၅၀ ကုဋေ
၃.၉၄ ကုဋေ
Total operating expenses
၃.၁၄ ကုဋေ
၄.၀၁ ကုဋေ
၄.၆၀ ကုဋေ
၃.၉၇ ကုဋေ
Operating income
-၁.၈၉ ကုဋေ
-၃.၈၅ ကုဋေ
-၄.၄၁ ကုဋေ
-၃.၄၂ ကုဋေ
Other non operating income
-၁.၄၀ သောင်း
-၄.၁၇ သိန်း
၃.၀၀ ထောင်
-၁.၃၀ သောင်း
EBT including unusual items
-၁.၆၇ ကုဋေ
-၃.၅၉ ကုဋေ
-၄.၁၅ ကုဋေ
-၃.၁၉ ကုဋေ
EBT excluding unusual items
-၁.၆၇ ကုဋေ
-၃.၅၉ ကုဋေ
-၄.၁၅ ကုဋေ
-၃.၁၉ ကုဋေ
Income tax expense
-
၂.၀၀ ထောင်
-
၃.၀၀ ထောင်
Effective tax rate
-
-၀.၀၁%
-
-၀.၀၁%
Other operating expenses
-
-
-
-
Net income
-၁.၆၇ ကုဋေ
-၃.၅၉ ကုဋေ
-၄.၁၅ ကုဋေ
-၃.၁၉ ကုဋေ
Net profit margin
-၁၃၃.၆၀%
-၂,၂၆၀.၄၅%
-၂,၁၈၂.၄၃%
-၅၈၁.၈၁%
Earnings per share
-၀.၅၉
-၁.၁၆
-၁.၃၂
-၁.၀၂
Interest and investment income
၂.၂၀ သန်း
၂.၉၉ သန်း
၂.၆၄ သန်း
၂.၂၇ သန်း
Interest expense
-
-
-
-
Net interest expenses
၂.၂၀ သန်း
၂.၉၉ သန်း
၂.၆၄ သန်း
၂.၂၇ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၈၈ ကုဋေ
-၃.၈၄ ကုဋေ
-၄.၄၀ ကုဋေ
-၃.၄၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ